EDG-7 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dodecylphosphate | 2627-35-2 | sc-221566 sc-221566A | 5 mg 25 mg | $152.00 $561.00 | ||
Dodecylphosphate, classified as an EDG-7, exhibits distinctive behavior as an acid halide, particularly through its capacity for self-assembly and micelle formation in solution. The long hydrophobic dodecyl chain enhances its surfactant properties, promoting unique molecular interactions at interfaces. Its reactivity is influenced by the phosphate group, which can engage in hydrogen bonding, affecting reaction kinetics and selectivity in various organic transformations. | ||||||
Ki16425 | 355025-24-0 | sc-221788 sc-221788A | 1 mg 5 mg | $199.00 $612.00 | 17 | |
A selective LPA receptor antagonist, potentially inhibiting LPAR3 by blocking its binding sites. | ||||||
Tetradecyl Phosphonate | 4671-75-4 | sc-205519 sc-205519A | 100 mg 500 mg | $24.00 $115.00 | ||
Tetradecyl Phosphonate, an EDG-7, showcases remarkable properties as an acid halide, particularly in its ability to form stable aggregates in polar solvents. The extended tetradecyl chain contributes to its amphiphilic nature, facilitating unique interactions with polar and nonpolar environments. Its phosphonate group enhances nucleophilicity, allowing for selective reactions with electrophiles, while also participating in complexation with metal ions, influencing catalytic pathways. | ||||||
MAFP | 188404-10-6 | sc-203440 | 5 mg | $219.00 | 4 | |
An inhibitor of phospholipase A2, can indirectly affect LPAR3 signaling by altering LPA levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially influencing LPAR3-related signaling pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, could indirectly influence LPAR3 signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor, might impact pathways related to LPAR3 signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, potentially affecting LPAR3-related MAPK/ERK signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, could indirectly affect LPAR3-related signaling pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, can impact cytoskeletal dynamics potentially related to LPAR3 signaling. | ||||||